Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Unknown cause of death; intravenous; This is a spontaneous report from a non-contactable consumer downloaded from the regulatory authority-WEB DE-PEI-CADR2021017125. An 82-year-old female patient received second dose of BNT162B2 (COMIRNATY), intravenous on 07Feb2021 (Lot Number: EL8723) at single dose for COVID-19 immunisation. Medical history included ongoing primary hyperthyroidism, ongoing atrial fibrillation and ongoing dyspnoea exertional. The patient''s concomitant medications were not reported. The patient previously received first dose of BNT162B2 (COMIRNATY) on 17Jan2021 for COVID-19 immunization. The patient death occurred on 13Feb2021, unknown cause of death. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166